HCPCS modifier › E codes › EB

EB

Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy

ValidHCPCS Level II modifier.

Valid for claims with a date of service in the current code year.

Valid FY2023 onwards.

What has happened to this code

Every change the publisher made, from 2025 to now.

  1. January 2025 Description revised Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy